We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Fisher Launches SpeciMax Raw Saliva Collection Kit for SARS-CoV-2 Surveillance Testing

By LabMedica International staff writers
Posted on 02 Mar 2021
Thermo Fisher Scientific Inc. More...
(Waltham, MA, USA) has launched its new SpeciMax raw saliva collection kit that will enable safe, cost-effective SARS-CoV-2 surveillance testing with a universal kit that fits within existing workflows and saves time and space over current, non-standardized collection methods.

Thermo Fisher’s SpeciMax is optimal for raw saliva collection as it can be self-administered with its medical grade packaged convenient funnel tube and cap. The kit contains a 6mL bar coded collection tube that seamlessly fits into current automation racks, thus saving time and space. SpeciMax is compatible with viral RNA extraction and direct to PCR workflows for easy and low-cost testing. The kit is compatible with MagMAX viral nucleic acid isolation kits (RUO), KingFisher, TaqCheck, TaqMan and other systems.

The SpeciMax raw saliva collection kit offers several benefits over nasal swab and nasopharyngeal collection such as non-invasive sample collection, self-administration and tube sized for automation racks. SpeciMax is available in single use individually packaged kits in cases of 400.





Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.